Greg has 20-plus years experience in healthcare communications. An award winning art director, writer and strategic partner. Greg was previously creative director / partner at SSW Communications in San Francisco, where he was instrumental in several product launches for Genentech, including Activase for stroke, Pulmozyme for COPD, and Nutropin for growth hormone deficiency. He also developed SSW's Corporate Communications division, which specialized in corporate branding, promotional campaigns, and annual reports for Genentech, Gilead, Deltagen and Exelixis.

Prior to SSW, Greg was Vice President, Associate Creative Director at FCB HealthCare. Among his achievements at FCB were the successful launch of Genentech's Activase and Pulmozyme, and Syntex-P&G's Aleve. Greg is most proud of the "Art.Rage.Us" work he created for The Breast Cancer Fund, which won Best of Show in the Medical Marketing Association's In Awe Awards. He served on The Breast Cancer Fund's Board of Directors for 5 years. Currently Greg provides creative solutions for both healthcare clients and advertising agencies.

Sampson & Company www.gsampson.com